Related Experiment Video

Updated: Jul 3, 2026

Promoting 3-D Aggregation of FACS Purified Thymic Epithelial Cells with EAK 16-II/EAKIIH6 Self-assembling Hydrogel
08:02

Promoting 3-D Aggregation of FACS Purified Thymic Epithelial Cells with EAK 16-II/EAKIIH6 Self-assembling Hydrogel

Published on: June 27, 2016

Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema

Dagmar Simon, Jennifer Wittwer, Ganna Kostylina

    The Journal of Allergy and Clinical Immunology
    |July 8, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jul 3, 2026

    Promoting 3-D Aggregation of FACS Purified Thymic Epithelial Cells with EAK 16-II/EAKIIH6 Self-assembling Hydrogel
    08:02

    Promoting 3-D Aggregation of FACS Purified Thymic Epithelial Cells with EAK 16-II/EAKIIH6 Self-assembling Hydrogel

    Published on: June 27, 2016

    Related Concept Videos

    Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

    Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

    Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

    Articles linked to this work by shared authors, journal, and citation graph.

    Empagliflozin in GSD-Ib: Long-term safety and sustained recovery of neutrophil function including NET formation.

    Molecular genetics and metabolism reports·2026

    Occupational Contact Allergy to Components of Epoxy Resin Systems: Descriptive and Comparative Epidemiological Analyses Based on IVDK Data 2008-2022.

    Contact dermatitis·2026

    Multiplex Cytokine LTT Reveals Strong T Cell Responses to Multiple Drugs in NIDHR-Associated Multiple Drug Hypersensitivity.

    The journal of allergy and clinical immunology. In practice·2026

    Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

    Allergologie select·2026

    Molecular Characterization of Non-Specific Esophagitis Reveals a Distinct Non-Eosinophilic Phenotype With Fibrotic Traits.

    Allergy·2026

    Patch Test Results With the European Baseline Series, 2021/2022-Joint European Results of the ESSCAA and the EBSB Working Groups of the ESCD, and the GEIDACC.

    Contact dermatitis·2026

    Early-Life Wheezing and Childhood Cognition in the ECHO Cohort.

    The Journal of allergy and clinical immunology·2026

    Tonsillar expression quantitative trait loci verify and expand genetic contributors to childhood atopic diseases.

    The Journal of allergy and clinical immunology·2026

    IL1A promotes inflammation while safeguarding epithelial basal cell identity and barrier function.

    The Journal of allergy and clinical immunology·2026

    Classroom Microbiome Signatures of Pest Management Associate with Reduced Asthma Symptoms.

    The Journal of allergy and clinical immunology·2026

    Context-Dependent Regulation of Mast Cell-Mediated Food Allergy in C57BL/6J Mice.

    The Journal of allergy and clinical immunology·2026

    SERPINB9 is associated with clinical improvement during aspirin therapy in aspirin-exacerbated respiratory disease.

    The Journal of allergy and clinical immunology·2026

    Pulmonary granular cell tumor coexisting with interstitial lung disease - a rare case report.

    Polish journal of pathology : official journal of the Polish Society of Pathologists·2026

    Levocetirizine-induced paradoxical fixed drug eruption: A case report with causality assessment.

    Indian journal of pharmacology·2026

    52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2026

    Dramatic Improvement of Treatment-Refractory Prurigo Nodularis Following Initiation of Semaglutide: A Case Report.

    Clinical, cosmetic and investigational dermatology·2026

    Correction: Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report.

    Frontiers in immunology·2026

    A Persistent Flexural Dermatosis Unmasking Adult Langerhans Cell Histiocytosis: A Case Report.

    Cureus·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us